pharmafakt has been supporting doctors” and pharmacists” professional associations, university research and the pharmaceutical industry since 1998 with comprehensive, differentiated and fundamentally data-backed studies and analyses as well as proven consulting expertise on all issues in the drugs market.
pharmafakt’s shareholders include the pharmacists” associations of the federal states of Bavaria, Baden-Württemberg and Saxony (SASG), NOVENTI GmbH, a leader in products and services in national and international health in Munich, and ARZ-Holdinggesellschaft für Softwareinnovationen mbH (an ARZ-Haan AG company).
The pharmafakt consulting concept is based on data obtained in data processing centres for pharmacies during prescription settlement. This data is anonymised and made available to a special trust centre.
There, the data is processed on behalf of pharmafakt on a project-specific basis and in a customised way to create statistics and analyses which are then available for our unique, individual and data-backed consulting expertise.
We call this data-backed pharma consulting.
The innovative pharmafakt concept - a tailored business-to-business partnership